(Q46030422)

18 December 2017

title

Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats. (English)

1 reference

18 December 2017

author name string

Jian Ping Gao

1

1 reference

18 December 2017

Chang Xun Chen

2

1 reference

18 December 2017

Ying Wang

3

1 reference

18 December 2017

Jian Lü

4

1 reference

18 December 2017

Wei Liang Gu

5

1 reference

18 December 2017

publication date

1 May 2009

1 reference

18 December 2017

Journal of Pharmacy and Pharmacology

published in

1 reference

18 December 2017

volume

61

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

677-683

1 reference

18 December 2017

The natural history of idiopathic dilated cardiomyopathy

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Isoproterenol and angiotensin I-converting enzyme in lung, left ventricle, and plasma during myocardial hypertrophy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

The renin-angiotensin-aldosterone system: a specific target for hypertension management

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Thyroid hormone action in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Metabolism of thyroid hormones in cultured cardiac fibroblasts of neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

The cardiac fibroblast: therapeutic target in myocardial remodeling and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.05.0018

21 January 2018

Identifiers

DOI

10.1211/JPP.61.05.0018

1 reference

18 December 2017

1 reference

18 December 2017